Wellspring Financial Advisors, LLC Novavax Inc Transaction History

Wellspring Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$69.73 - $142.9 $118,541 - $242,930	-1,700 Closed	0 $0
Q4 2021 Jan 03, 2022	BUY	$134.56 - $217.97 $26,912 - $43,594	200 Added 13.33%	1,700 $243,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $17,780 - $27,058	100 Added 7.14%	1,500 $311,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $169,400 - $360,738	1,400 New	1,400 $297,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Wellspring Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wellspring Financial Advisors, LLC with notifications on news.